XLO
Xilio Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.51
+0.00 -0.23%
🌙 3월 13일 7:12 PM ET (한국 3/14 08:12)
$0.51
+0.00 +0.08%
| Index | - | P/E | - | EPS (ttm) | -0.66 | Insider Own | 56.76% | Shs Outstand | 0.05B | Perf Week | -3.75% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | - | Insider Trans | -0.02% | Shs Float | 0.03B | Perf Month | -4.65% |
| Enterprise Value | -0.06B | PEG | - | EPS next Q | - | Inst Own | 25.83% | Short Float | 6.66% | Perf Quarter | -28.97% |
| Income | -0.06B | P/S | 1.18 | EPS this Y | - | Inst Trans | -2.17% | Short Ratio | 4.67 | Perf Half Y | -30.09% |
| Sales | 0.03B | P/B | - | EPS next 5Y | - | ROA | -56.14% | Short Interest | 2.11M | Perf YTD | -20.32% |
| Book/sh | -0.16 | P/C | 0.36 | EPS past 3/5Y | 26.76% -11.55% | ROE | -908.28% | 52W High | -56.77% ($1.18) | Perf Year | -36.16% |
| Cash/sh | 1.41 | P/FCF | - | Sales past 3/5Y | - | ROIC | - | 52W Low | 10.46% ($0.46) | Perf 3Y | -82.53% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 61.76% | Gross Margin | 94.77% | Volatility(W/M) | 8.5% 8.17% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | -1.86 | Sales Y/Y TTM | 588.4% | Oper. Margin | -137.64% | ATR (14) | 0.04 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.2 | EPS Q/Q | 48.85% | Profit Margin | -183.9% | RSI (14) | 37.42 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.2 | Sales Q/Q | 742.51% | SMA20 | -6.39% ($0.54) | Beta | -0.03 | Target Price | $2 |
| Payout | - | Debt/Eq | - | Earnings | 11000000 | SMA50 | -13.38% ($0.59) | Rel Volume | 0.95 | Prev Close | $0.51 |
| Employees | 64 | LT Debt/Eq | - | EPS/Sales Surpr. | -244.83% 2.5% | SMA200 | -26.7% ($0.7) | Avg Volume(3M) | 0.45M | Price | $0.51 |
| IPO | 2021/10/22 | Option/Short | No/Yes | Trades | 1940 | Volume | 431,249 | Change | -0.23% |
뉴스 로딩 중...